A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Clinical trial NCT03767244 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03767244
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-11
- Primary completion
- 2026-12-01
- Enrollment
- 2517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.